Ruiting Guo

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Christine A. Shaw, Brandon Essink, Charles Harper et al. · The Journal of Infectious Diseases · 2024 · 50 citations · Full text

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy

Yifan Zhao, Xiaomei Zhang, Meng Zhang et al. · Annals of Hematology · 2024 · 27 citations

Hematological Malignancy, Translational Medicine, Medicine +15

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Xiaomei Zhang, Hairong Lv, Xia Xiao et al. · Blood · 2023 · 21 citations

Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escape

Danni Xie, Xin Jin, Rui Sun et al. · Translational Oncology · 2023 · 18 citations · Full text

mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trial

Amanda K Rudman Spergel, Jintanat Ananworanich, Ruiting Guo et al. · Nature Medicine · 2025 · 12 citations